Primary Care Diabetes
Volume 2, Issue 3 , Pages 147-153 , September 2008

The “metabolic syndrome” is less useful than random plasma glucose to screen for glucose intolerance

  • Eman A. El Bassuoni

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • On sabbatical leave from El Minia University School of Medicine, Egypt.
    • ,
  • David C. Ziemer

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • Paul Kolm

      Affiliations

    • Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • Current address: Christiana Hospital, Newark, DE, United States.
    • ,
  • Mary K. Rhee

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • Viola Vaccarino

      Affiliations

    • Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • Circe W. Tsui

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • Jack M. Kaufman

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • G. Eileen Osinski

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • David D. Koch

      Affiliations

    • Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • ,
  • K.M. Venkat Narayan

      Affiliations

    • Hubert Department of Global Health, Rollins School of Public Health, Atlanta, GA, United States
    • ,
  • William S. Weintraub

      Affiliations

    • Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • Current address: Christiana Hospital, Newark, DE, United States.
    • ,
  • Lawrence S. Phillips

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
    • Veterans Administration Medical Center, Atlanta, GA, United States
    • Corresponding Author InformationCorresponding author at: Division of Endocrinology and Metabolism, Emory University School of Medicine, 101 Woodruff Circle, WMRB Room 1027, Atlanta, GA 30322, United States. Tel.: +1 404 717 1392; fax: +1 404 727 1300.

Received 10 January 2008 ,Revised 6 March 2008 ,Accepted 27 April 2008.

References 

  1. Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29:2114–2116
  2. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann. Intern. Med. 2001;135:825–834
  3. American Diabetes Association . Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917–932
  4. The Diabetes Control Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  5. UK Prospective Diabetes Study Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  6. Stettler C, Allemann S, Juni P, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am. Heart J. 2006;152:27–38
  7. Buchanan TA. (How) can we prevent type 2 diabetes?. Diabetes. 2007;56:1502–1507
  8. Ferrannini E, Vichi S, Beck-Nielsen H, et al. Insulin action and age. Diabetes. 1996;45:947–953
  9. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001;24:925–932
  10. Franks PW, Ekelund U, Brage S, et al. Does the Association of Habitual Physical Activity with the metabolic syndrome differ by level of cardiorespiratory fitness?. Diabetes Care. 2004;27:1187–1193
  11. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 1999;104:787–794
  12. Cheal KL, Abbasi F, Lamendola C, et al. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004;53:1195–1200
  13. Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care. 2006;29:1693–1696
  14. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 2006;91:2906–2912
  15. Meigs JB. Epidemiology of the metabolic syndrome. Am. J. Manage. Care. 2002;8:S283–S292
  16. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444–2449
  17. Meigs JB, Rutter MK, Sullivan LM, et al. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30:1219–1225
  18. Park Y-W, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 2003;163:427–436
  19. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  20. Sorkin JD, Muller DC, Fleg JL, Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care. 2005;28:2626–2632
  21. Kanaya AM, Herrington D, Vittinghoff E, et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann. Intern. Med. 2005;142:813–820
  22. Harrell FE. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression and Survival Analysis. New York: Springer-Verlag; 2001;
  23. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845
  24. Ealovega MW, Tabaei BP, Brandle M, et al. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care. 2004;27:9–12
  25. Schulz LO, Bennett PH, Ravussin E, et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S.. Diabetes Care. 2006;29:1866–1871
  26. Bloomgarden ZT. Insulin resistance concepts. Diabetes Care. 2007;30:1320–1326
  27. Racette SB, Evans EM, Weiss EP, et al. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50–95 year olds. Diabetes Care. 2006;29:673–678
  28. Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27:1496–1504
  29. Park PJ, Griffin SJ, Sargeant L, Wareheim NJ. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care. 2002;25:984–988
  30. Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care. 2006;29:410–414
  31. Meigs JB, Williams K, Sullivan LM, et al. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care. 2004;27:1417–1426
  32. Nelson KM, Boyko EJ. Predicting impaired glucose tolerance using common clinical information. Diabetes Care. 2003;26:2058–2062
  33. Schmidt MI, Duncan BB, Vigo A, et al. Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2003;26:1338–1343
  34. Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28:2013–2018
  35. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of Type 2 diabetes. Diabetes Care. 2004;26:3153–3159
  36. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for Type 2 diabetes mellitus: do we need the oral glucose tolerance test?. Ann. Intern. Med. 2002;136:575–581
  37. Haffner SM, Williams K, Stern MP, Hunt KJ, D’Agostino R, Wagenknecht LE. Impaired glucose tolerance (IGT) vs. a predicting model for type 2 diabetes as predictors of diabetes and common carotid wall thickness (CC-IMT): the insulin resistance atherosclerosis study (IRAS). Diabetes. 2002;51(Suppl. 2):A227;(Abstract)
  38. Aekplakorn W, Bunnag P, Woodward M, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care. 2006;29:1872–1877
  39. Klein BEK, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25:1790–1794
  40. Bonora E, Kiechl S, Willeit J, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes. 2004;53:1782–1789
  41. Cheung BM, Wat NM, Man YB, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30:1430–1436
  42. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program—Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30:8–13
  43. Mattsson N, Ronnemaa T, Juonala M, et al. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J. Intern. Med. 2007;261:159–169
  44. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29:151–153

PII: S1751-9918(08)00039-9

doi: 10.1016/j.pcd.2008.04.005

Primary Care Diabetes
Volume 2, Issue 3 , Pages 147-153 , September 2008

Article Tools

* Image Usage & Resolution